Loading organizations...
Key people at Integra Holdings.
Integra Holdings invests in and commercializes early-stage life science technologies originating from the Hebrew University of Jerusalem. It functions as a technology transfer vehicle, supporting startups in regenerative medicine, biotech, and related fields by bridging academic innovation to market-ready solutions. The firm is funded by institutional shareholders, including Temasek and Consensus Business Group (CBG), generating returns through its investments and technology commercialization. Its network includes entities like Invatech Holdings and Halman-Aldubi Investment Group, facilitating the advancement of university-derived intellectual property. Specific financial metrics or scale indicators for Integra Holdings are not publicly available. Integra Holdings was founded in 2012 by Yissum, the technology transfer company of the Hebrew University of Jerusalem. Its business model centers on funded by institutional shareholders including Temasek, Consensus Business Group, and others, generates returns through investments in portfolio companies and technology commercialization.
Integra Holdings has 1 tracked investment across 1 company. The latest tracked deal is $30.0M Series F in Atox Bio in December 2017.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 1, 2017 | Atox Bio | $30.0M Series F | Jonathan Tobin | Brandon Capital Partners, Terry Gould, Asahi Kasei, Becker Ventures, Lundbeckfond Ventures, OrbiMed, SR ONE |
Key people at Integra Holdings.